Linde (LIN) opened 2026 on the back of a solid run of results, with Q4 2025 revenue at US$8.8b, basic EPS of US$3.28 and trailing twelve month EPS of US$14.69 setting the scene for its latest Q1 2026 update and giving investors clear earnings markers to judge against. Over the past year, revenue has ranged from US$8.1b to US$8.8b a quarter, while quarterly basic EPS has moved between US$3.28 and US$4.11, supported by trailing twelve month net income of US$6.9b. The focus now is on how far margin strength and ongoing earnings growth can keep powering the story.

See our full analysis for Linde.

With the headline numbers on the table, the next step is to line them up against the widely followed Linde narratives to see which stories fit the data and which ones start to look stretched.

20.3% net margin keeps profitability high

• Over the last 12 months, Linde generated about US$6.9b in net income on US$34.0b of revenue, which equates to a 20.3% net profit margin compared with 19.9% a year earlier.
• Consensus narrative points to long term margin support from digitalization, operational efficiency, and decarbonization projects, and that lines up with the current 20.3% margin. However, risks around weaker industrial demand and potential oversupply highlight how sensitive those margins could be if volumes or pricing come under pressure.
  • Supporters of the bullish angle highlight a doubled project backlog anchored by long term fixed fee contracts and almost US$5.0b of new clean energy contracts, which is consistent with the idea of steady, recurring profit streams.
  • At the same time, concerns about structural pressures in Europe and pricing challenges in areas like helium in Asia show that even with a 20.3% margin, exposure to slower regions and more competitive products remains an important watchpoint.

Five year earnings growth vs 5.1% recent pace

• Linde's earnings have grown 17.9% per year over the past five years, compared with 5.1% earnings growth over the last year and analyst expectations of about 9.33% earnings growth and 5.8% revenue growth per year going forward.
• What stands out for the bullish narrative is that long term earnings growth of 17.9% a year and a current 20.3% net margin support the idea of durable profit expansion. Yet the more recent 5.1% earnings growth and forecast mid single digit revenue growth show that the pace already looks closer to the more moderate outlook analysts are using.
  • Backers of the bullish view lean on multi year drivers such as revenue growing an assumed 5.3% annually to reach about US$39.7b and earnings reaching US$9.0b by 2029, which would lift EPS from US$14.69 over the last 12 months to a projected US$20.25.
  • Set against that, the fact that trailing earnings sit around US$6.9b and analysts are building only mid to high single digit annual growth into those US$9.0b forecasts suggests expectations are already moderate rather than aggressive. That gives you a reference point when you compare current trends with the longer term story.

On these growth numbers, it helps to see how bullish and cautious investors each read the same earnings path 🐂 Linde Bull Case

P/E of 34x with price above DCF fair value

• The shares trade on a trailing P/E of 34x at a current price of US$507.92, above the US Chemicals industry average of 26.8x and above a DCF fair value of about US$386.90, while an allowed analyst price target reference of US$526.89 sits only modestly higher than today.
• Critics highlight that paying 34x earnings when the DCF fair value figure is US$386.90 and when earnings are forecast to grow around 9.33% a year leaves less room for error. They also point to a high debt load and recent insider selling over the past three months as extra pressure points to weigh against the company’s strong five year earnings record and 20.3% net margin.
  • Bears argue that the combination of a P/E premium to the 26.8x industry average and a share price above the DCF fair value suggests the stock already embeds confidence in continued growth and margin strength, even though revenue is expected to grow at about 5.8% a year, slower than the broader US market forecast in the dataset.
  • They also underline that significant insider selling and high debt, even described as a minor risk, add to the valuation debate because they sit alongside that premium multiple and the relatively tight gap between the current US$507.92 share price and the US$526.89 analyst target used here.

If you are weighing whether this 34x P/E is justified, it is worth reading how skeptics connect debt, insider selling, and valuation tension to their thesis 🐻 Linde Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Linde on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mix of optimism and concern in this update, it makes sense to check the numbers yourself and decide how comfortable you are with the balance of risks and rewards. To see both sides laid out clearly, review the 2 key rewards and 2 important warning signs

See What Else Is Out There

With a 34x P/E above both industry averages and the DCF estimate, plus insider selling and a high debt load, valuation risk stands out.

If that combination feels a bit stretched, compare it with companies screened for stronger balance sheets and fundamentals using the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.